Pharmaceutical Vitamin B1 Pyridoxal-5-Phosphate Benfotiamine CAS No 22457-89-2 Benfotiamine

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Solid
• Purity: >98%
• Model NO.: Benfotiamine
• Name: Benfotiamine
• Mf: C19h23n4o6PS
• CAS: 22457-89-2
• Transport Package: Drum
• Specification: 99%
• Trademark: HS
• Origin: China
• HS Code: 2904201000
• Production Capacity: 100000

Product Description

Treatment of Vitamin B1 Deficiency CAS 22457-89-2  Benfotiamine Powder

 

Product Description:
Benfotiamine is vitamin B1 fat soluble derivatives, improve the bioavailability of water-soluble vitamin B1 low shortcomings, improve the blood and tissue concentrations of thiamine, so as to improve the curative effect.
Benfotiamine is primarily marketed as an antioxidant dietary supplement. In a clinical study with six patients, benfotiamine lowered AGE by 40%.

Function:
Benfotiamine is useful for the treatment of diabetic retinopathy, neuropathy, and nephropathy however "Most of the effects attributed to benfotiamine are extrapolated from in vitro and animal studies. Unfortunately apparent evidences from human studies are scarce and especially endpoint studies are missing. Therefore additional clinical studies are mandatory to explore the therapeutic potential of benfotiamine in both diabetic and non-diabetic pathological conditions".
It is thought that treatment with benfotiamine leads to increased intracellularthiamine diphosphate levels, a cofactor of transketolase. This enzyme directs advanced glycation and lipoxidation end products (AGE's, ALE's) substrates to the pentose phosphate pathway, thus reducing tissue AGEs.
 
Application Area:
1. Benfotiamine is used for the prevention and treatment of vitamin B1 deficiency; 
2. For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation, during strenuous manual labor, etc.);
3. Benfotiamine is used in the treatment of non alcoholic wernicke encephalopathy;
4. To treat beriberi; 
5. Used in the following diseases, speculation and vitamin B1 deficiency and metabolic disorders associated with treatment, such as: neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve palsy; Myocardial metabolic disorders; Constipation and other gastrointestinal motor function obstacle.

FAQ
Application Area:
Uridine 5-Mophosphate Disodium are produced through the hydrolytic reaction from Ribonucleic acid(RNA) as raw material by enzymatic catalysis to form four kinds of nucleotides 5- 'AMP (adenosine-5'-monophosphate), 5'-GMP•2Na(guanosine-5'-monophosphate, disodium salt), 5'-CMP(cytidine-5'-monophosphate)-, 5'-UMP•2Na (uridine- 5'-monophosphate,Disodium salt) .By the chromatographic isolation, four kinds of separated 5'-nucleotide products with high purity can be obtained. These products can be widely applied in medicine, reagent, fine chemical industry, and additive of food fields etc.
 
1. Benfotiamine powder is used for the prevention and treatment of vitamin B1 deficiency; 
2. For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation, during
strenuous manual labor, etc.);
3. Benfotiamine is used in the treatment of nonalcoholic wernicke encephalopathy;
4. To treat beriberi; 
5. Used in the following diseases, speculation, and vitamin B1 deficiency and metabolic disorders associated with treatment, such as:
neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve palsy; Myocardial metabolic disorders; Constipation and other
gastrointestinal motor function obstacle.

Test  Item	Analysis  Specification	Result
Description	White to almost white crystal	White to almost white crystal
Identification	A: IR spectra shows the similarity between sample and standard B: The retention time of the major peak corresponds with it of the reference standard	Complies Complies
Solution color and clearness	Colorless to a pale yellow clear solution	Complies
Chlorides	Not more than 0.053%	<0.053%
Sulphate	Not more than 0.011%	<0.011%
Loss on drying	Not more than 1.5%	0.66%
Heavy metals	Not more than 0.002%	<0.002%
Related Substances	TMP :Not more than 0.15% Benzoic acid: not more than0.1% Amide: not more than 0.40% Single unknown impurity: not more than0.1% Thiamine: not more than0.1% Total impurities: Not more than 1.5%	<0.025% No detectable 0.06% 0.08% No detectable 0.33%
Residual solvents	Dichloromethane: not more than 600ppm Isopropanol: not more than300ppm	No detectable 64ppm
Microbial limits	Total bacteria: not more than100cfu/g Yeast and mold: not more than50cfu/g Escherichia coli: no detectable	<10 cfu/g <10 cfu/g No detectable
Assay(Dry Basis)	98.0%~102.0%	99.6%
Conclusion	Complies with company Standard.